Globe Newswire01.13.20
Integrity Applications Inc., innovator of GlucoTrack, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, has appointed David Malka as president, effective immediately.
Malka has served in various senior positions at Integrity since co-founding the company in 2001. Malka, who will report directly to the Board of Directors, currently serves as vice president of operations. He has extensive expertise in management, production, purchasing and logistics. As a co-founder, Malka has played an integral role in the development of GlucoTrack and has broad institutional knowledge and a valuable historical perspective.
Prior to his tenure at Integrity, Malka served as a vice president of operations for Solid Systems, manager of production and purchasing at Kollmorgen-Servotronix, and as a production designer at TFL Time & Frequency Systems Limited. Malka earned a degree in practical engineering – industrial management from the Institute of Work & Production Productivity, Tel-Aviv, as well as a bachelor of arts degree in management from the Open University of Israel.
GlucoTrack is a non-invasive monitoring device that rapidly measures and displays an individual’s glucose level in about a minute without finger pricking or any pain. GlucoTrack features a small sensor that clips to the earlobe and measures the user’s glucose level using patented sensor technologies. The measured signals are analyzed using a proprietary algorithm and then a calculated glucose level is displayed on a small handheld device the size of a small mobile phone. The glucose results are stored in the device and used to estimate HbA1c level using a proprietary algorithm. The device can also display glucose values graphically, enabling the user to monitor glucose levels over time. GlucoTrack has received approvals for CE Mark in Europe and from the Ministry of Food and Drug Safety in South Korea for type 2 diabetes and pre-diabetics and is currently available in selected markets in Europe and Asia.
Integrity Applications Inc. was founded in 2001 and is focused on the design, development, and commercialization of non-invasive glucose monitoring technologies for people with type 2 diabetes and prediabetes. The company has developed GlucoTrack, a proprietary non-invasive glucose monitoring device designed to obtain glucose level measurements in about a minute without the pain, incremental cost, difficulty, or discomfort of conventional invasive finger stick devices. Integrity Applications Inc. is a Delaware corporation, with headquarters in the United States and an R&D site in Ashdod, Israel.
Malka has served in various senior positions at Integrity since co-founding the company in 2001. Malka, who will report directly to the Board of Directors, currently serves as vice president of operations. He has extensive expertise in management, production, purchasing and logistics. As a co-founder, Malka has played an integral role in the development of GlucoTrack and has broad institutional knowledge and a valuable historical perspective.
Prior to his tenure at Integrity, Malka served as a vice president of operations for Solid Systems, manager of production and purchasing at Kollmorgen-Servotronix, and as a production designer at TFL Time & Frequency Systems Limited. Malka earned a degree in practical engineering – industrial management from the Institute of Work & Production Productivity, Tel-Aviv, as well as a bachelor of arts degree in management from the Open University of Israel.
GlucoTrack is a non-invasive monitoring device that rapidly measures and displays an individual’s glucose level in about a minute without finger pricking or any pain. GlucoTrack features a small sensor that clips to the earlobe and measures the user’s glucose level using patented sensor technologies. The measured signals are analyzed using a proprietary algorithm and then a calculated glucose level is displayed on a small handheld device the size of a small mobile phone. The glucose results are stored in the device and used to estimate HbA1c level using a proprietary algorithm. The device can also display glucose values graphically, enabling the user to monitor glucose levels over time. GlucoTrack has received approvals for CE Mark in Europe and from the Ministry of Food and Drug Safety in South Korea for type 2 diabetes and pre-diabetics and is currently available in selected markets in Europe and Asia.
Integrity Applications Inc. was founded in 2001 and is focused on the design, development, and commercialization of non-invasive glucose monitoring technologies for people with type 2 diabetes and prediabetes. The company has developed GlucoTrack, a proprietary non-invasive glucose monitoring device designed to obtain glucose level measurements in about a minute without the pain, incremental cost, difficulty, or discomfort of conventional invasive finger stick devices. Integrity Applications Inc. is a Delaware corporation, with headquarters in the United States and an R&D site in Ashdod, Israel.